Skip to content

The effect of collagen-containing supplementation on pain, quality of life and functional parameters in osteoarthritis patients

Effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on osteoarthritis-related pain, quality of life and physical function: a randomized, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240411061470N1
Enrollment
40
Registered
2024-04-15
Start date
2023-12-04
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Unilateral primary osteoarthritis, unspecified knee

Interventions

Intervention 1: Intervention group: Participants used one sachet of Naturagen® 4 Joint product daily for 8 weeks. Intervention 2: Control group: Participants used a placebo product with the same appea

Sponsors

Ondokuz Mayis University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosed with unilateral or bilateral Kellgren and Lawrence radiographic grade 2 or 3 knee OA for more than 3 months Non-vegetarian Willing to participate in all scheduled visits and tests

Exclusion criteria

Exclusion criteria: Kellgren and Lawrence diagnosed with radiographic grade 1 or 4 knee OA Any history of trauma, fracture or surgery on the index joint Evidence or history of clinically significant hematologic, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases or malignancies within the last 5 years History of hypersensitivity to the rescue medication or any of the products used in the study Active viral or bacterial infection according to clinical examination Expected knee arthroscopy or arthroplasty or life-threatening pathology Received intra-articular injections or corticosteroids in the target knee joint (the most painful knee at screening) within the last 6 months Patients with intolerance to protein-based foods or supplements, pregnant or breastfeeding women and those with alcohol dependence

Design outcomes

Primary

MeasureTime frame
Pain Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Western Ontario and McMaster Universities Osteoarthrtis Index (WOMAC), Visual Analogue Scale (VAS).;Quality of Life Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Oxford Knee Score (OKS), Tampa Scale for Kinesiophobia (TSK), Short Form Health Survey (SF-12), Foot Function Index (FFI).;Balance Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Berg Balance Scale (BBS).;Functional Performance Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Timed Up and Go (TUG), 6-Minute Walking Test (6MWT), The Five Repetition Sit to Stand Test (5STS), Stair-Climbing Test (SCT).

Countries

Turkey

Contacts

Public ContactAli Kerim Yilmaz

Ondokuz Mayis University

akerim.yilmaz@omu.edu.tr+90 542 495 37 37

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026